The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Opinion

Dipeptidyl Peptidase-4 억제제와 Sodium Glucose Cotransporter 2 억제제의 새로운 안전성 이슈: 어떻게 해석하고 진료현장에 적용할 것인가?: Nam Hoon Kim, Sin Gon Kim; J Korean Diabetes. 2017;18(3):135-140. Published online October 12, 2017; DOI: https://doi.org/10.4093/jkd.2017.18.3.135

Focused Issues

SGLT2 억제제의 부작용: Won Jin Kim, Sang Soo Kim; J Korean Diabetes. 2014;15(3):158-162. Published online September 30, 2014; DOI: https://doi.org/10.4093/jkd.2014.15.3.158
Cited By 5

SGLT2 억제제의 혈당조절과 무관한 작용: Dae Ho Lee; J Korean Diabetes. 2014;15(3):151-157. Published online September 30, 2014; DOI: https://doi.org/10.4093/jkd.2014.15.3.151
Cited By 1

SGLT2 억제제의 혈당 강하 효과: Hae Jin Kim; J Korean Diabetes. 2014;15(3):146-150. Published online September 30, 2014; DOI: https://doi.org/10.4093/jkd.2014.15.3.146

포도당 대사에서 신장의 역할: Sang Youl Rhee; J Korean Diabetes. 2014;15(3):142-145. Published online September 30, 2014; DOI: https://doi.org/10.4093/jkd.2014.15.3.142
Cited By 1

Volume 25, No. 4

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

5,129	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
1,657	Technological Innovations Transforming Diabetes Care in Practice
3,005	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
1,574	Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity
1,564	A Young Adult’s Life with Diabetes Based on a Social Ecological Model

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2025 by Korean Diabetes Association. All rights reserved.